CALLIDITAS THERAPEUTICS AB financial statements, including revenue, expenses, profit, and loss
The total revenue of LC8 for the last quarter is 25.58 M EUR, and it's 36.66% lower compared to the previous quarter. The net income of Q1 24 is -21.31 M EUR.